VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes
about
New insights into an X-traordinary viral proteinSAMHD1-Dependent and -Independent Functions of HIV-2/SIV Vpx ProteinIdentification and characterization of naturally occurring splice variants of SAMHD1Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significanceThe human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infectionThe restriction factors of human immunodeficiency virusVpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 proteinLocalization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor proteinVpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophagesThe range of human APOBEC3H sensitivity to lentiviral Vif proteinsThe Expression of Functional Vpx during Pathogenic SIVmac Infections of Rhesus Macaques Suppresses SAMHD1 in CD4+ Memory T CellsLentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infectionEvolution of the primate lentiviruses: evidence from vpx and vprA domain of human immunodeficiency virus type 1 Vpr containing repeated H(S/F)RIG amino acid motifs causes cell growth arrest and structural defects.Identification of critical regions in human SAMHD1 required for nuclear localization and Vpx-mediated degradationTargeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx.The envelope glycoprotein of human immunodeficiency virus type 2 enhances viral particle release: a Vpu-like factor?Vpr-induced cell cycle arrest is conserved among primate lentiviruses.Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particlesHuman immunodeficiency virus type 2 preintegration complexes: activities in vitro and response to inhibitors.Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes.A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitroEvidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions.Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophagesAmino acid changes in the fourth conserved region of human immunodeficiency virus type 2 strain HIV-2ROD envelope glycoprotein modulate fusionDispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication.Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophageMutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM).Pattern of transcription of the genome of equine infectious anemia virus.Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells.Genetic regulation of human immunodeficiency virus.Vpx rescue of HIV-1 from the antiviral state in mature dendritic cells is independent of the intracellular deoxynucleotide concentration.Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity.HIV-2 Vpx protein interacts with interferon regulatory factor 5 (IRF5) and inhibits its function.Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?Roles of Vpr and Vpx in modulating the virus-host cell relationship.Restricted access to myeloid cells explained.
P2860
Q21131105-AB6A5F53-DE34-416A-8C43-8BE1E03C3CCAQ21131138-8E7C05CC-C557-4D19-B900-2302564BF810Q21245040-B4183BE5-FD62-4999-9C94-363B248CC09DQ24307975-C1D4F0F3-61CE-4416-95F6-3D0727D12556Q24318267-A22B1777-6A9A-4574-B6FE-717835FD81D8Q24605108-C5B8142D-5C04-498D-9D06-92FFCBF401D1Q24635842-8732B17A-1B55-46BF-858C-5B00951EFC2DQ24645706-AFB16BE0-1094-4FD6-82BA-A4675DB7449EQ24651077-BAB3AF1D-D8A2-4750-BA96-45D8866E7343Q24653931-82E1D736-A33B-4609-BB68-FD90B071214CQ27319577-7C4F056B-79EC-44E4-B850-8D542C06C5A9Q28472652-DACDA877-9DAE-40B8-A44F-F3E22D8387C1Q33938392-A60507A6-3F67-45E9-9F22-A65D1F63CA1EQ34501320-4BC7912E-3F0C-4302-A9D0-C7C9357EB081Q34846363-C19862F3-C0A0-4D0F-8FFB-0B9612BAC065Q35839628-88BB245B-140C-42F2-915C-0259DBF74261Q35854386-4CE4FCB5-C189-4F80-933B-EB5C94EAC690Q35859146-1EAB1225-7489-4514-93CE-3754B1D33855Q35860937-D61DF9D1-41FF-47BA-80D5-53FD49F61F41Q35882060-CC98CF75-DEED-4F4B-A2AD-86E60D148FDBQ35888756-A7CBCFAC-C76B-4C1B-90AC-521A8987FA29Q36249990-E648814A-E7A6-44EC-B90F-8B288B4EB7CDQ36422635-B2D5B4C8-CA73-4925-92E6-C9C2FEE57FF0Q36484010-3264EF1F-B31D-4B78-BC55-B40B12F93C7FQ36650496-29B8C482-A7E0-4EB8-98C8-588BCA4925BEQ36650619-15079AC8-785E-4888-A327-DA80F1E917F6Q36653891-DED7C653-16CC-436E-A9F8-5896A5489F63Q36701891-AB4C711E-937A-4E84-9117-8A0D71B75C94Q36770468-9E59A357-381C-48F6-ABC2-629586E15621Q36797922-564468AA-0A6A-487E-802E-9C6B7A7522EAQ36800949-99624904-A977-4C9D-A54C-92F3E0135332Q36804377-B4E5B3FB-6FDA-4AFE-8E47-A5E874B009B5Q36994727-20520412-C574-4608-A1BA-45229B89EADBQ37056955-CFCCDE21-1772-412C-BEC5-D7198B7BFFBFQ37581713-CCED4962-1717-4EDE-8612-B6C286C0F333Q37633631-417DC5C7-8E37-4EAC-A620-25831A33A0FCQ37691600-181C6EBA-E14C-48D3-BCAB-C1EF699C25C8Q37728096-8392B63B-5298-422A-84E7-AA326716C0AFQ37766007-4B03A75E-745C-4FC0-93B4-CA885EEDEC02Q37945243-04F00CD3-863F-447F-9E67-77DB24BDB872
P2860
VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
VPX mutants of HIV-2 are infec ...... n peripheral blood lymphocytes
@ast
VPX mutants of HIV-2 are infec ...... n peripheral blood lymphocytes
@en
VPX mutants of HIV-2 are infec ...... peripheral blood lymphocytes.
@nl
type
label
VPX mutants of HIV-2 are infec ...... n peripheral blood lymphocytes
@ast
VPX mutants of HIV-2 are infec ...... n peripheral blood lymphocytes
@en
VPX mutants of HIV-2 are infec ...... peripheral blood lymphocytes.
@nl
prefLabel
VPX mutants of HIV-2 are infec ...... n peripheral blood lymphocytes
@ast
VPX mutants of HIV-2 are infec ...... n peripheral blood lymphocytes
@en
VPX mutants of HIV-2 are infec ...... peripheral blood lymphocytes.
@nl
P2093
P2860
P1433
P1476
VPX mutants of HIV-2 are infec ...... n peripheral blood lymphocytes
@en
P2093
P2860
P304
P407
P577
1989-04-01T00:00:00Z